Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
€21.00

€21.00

-2.800%
-0.6
-2.800%
€33.94
 
23.12.25 / Tradegate WKN: A1W2RM / Symbol: AGIO / Name: Agios / Stock / Biotechnology & Medical Research / Mid Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.

Agios Pharmaceuticals Inc. Stock

We can see a decrease in the price for Agios Pharmaceuticals Inc.. Compared to yesterday it has lost -€0.600 (-2.800%).
With 14 Buy predictions and only 1 Sell predictions the community sentiment for the stock is positive.
As a result the target price of 33 € shows a very positive potential of 57.14% compared to the current price of 21.0 € for Agios Pharmaceuticals Inc..
Criterium "Worthwhile Investment for the next years" is seen as the biggest plus for Agios Pharmaceuticals Inc. stock. Negative votes have not been in the majority for any criteria for this stock

Pros and Cons of Agios Pharmaceuticals Inc. in the next few years

Pros
?
C******** o* t** e**********
?
M***** P*******
?
S********** s********
Cons
?
W********* I********* f** t** n*** y****
?
G***** c******* t* c**********
?
B****
Tell us your opinion to access the 'Wisdom of the Crowds'

Comments

Prediction Buy
Perf. (%) -
Target price 33.936
Change
Ends at 26.12.26

Agios Pharmaceuticals (NASDAQ:AGIO) was given a new $40.00 price target on by analysts at Leerink Partners. They now have an "outperform" rating on the stock.
Ratings data for AGIO provided by MarketBeat
Show more

Agios Pharmaceuticals (NASDAQ:AGIO) had its "buy" rating reaffirmed by analysts at Citigroup Inc..
Ratings data for AGIO provided by MarketBeat
Show more

Prediction Buy
Perf. (%) -
Target price
Change
Ends at

Ratings data for AGIO provided by MarketBeat
Show more

News

Here's Why Shares in Agios Pharmaceuticals Popped Today: https://g.foolcdn.com/editorial/images/848673/gettyimages-516077862-1201x820-96628fa.jpg
Here's Why Shares in Agios Pharmaceuticals Popped Today

Shares in Agios Pharmaceuticals (NASDAQ: AGIO) soared by more than 18% as of 11 a.m. today. The move follows the company's receipt of approval from the Food and Drug Administration (FDA) for AQVESME

Why Shares in Agios Pharmaceuticals Got Crushed Today: https://g.foolcdn.com/editorial/images/843604/gettyimages-1125894475-1201x801-d21b45d.jpg
Why Shares in Agios Pharmaceuticals Got Crushed Today

Shares in Agios Pharmaceuticals (NASDAQ: AGIO) crashed by 50% by noontime today. The move comes as the market digests a mixed set of topline results from its Phase 3 trial (RISE UP) of its sickle

Agios (AGIO) Q2 Revenue Jumps 45%
Agios (AGIO) Q2 Revenue Jumps 45%

Agios Pharmaceuticals (NASDAQ:AGIO), a biotechnology company focused on therapies for rare blood disorders, released its second quarter 2025 earnings on July 31, 2025. The headline was a notable